|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 38/31 | |||
| A61K 49/00 |
| (11) | Number of the document | 2359809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10175382.0 |
| Date of filing the European patent application | 2006-12-20 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0526247 | 2005-12-22 | GB | |
| 06119086 | 2006-08-17 | EP |
| (72) |
Petersen, Holger, DE
Ahlheim, Markus, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |